Sernova Company
Sernova develops regenerative medicine therapeutic technologies for treatment of chronic metabolic diseases.
Total Funding:
$6.2M
Headquarters:
Canada
Funding Status:
IPO
Employee Number:
1-10
Estimated Revenue:
$100M to $500M
Investment Stage:
N/A
Last Funding Type:
Post-IPO Equity
Number Of Exists:
Post-IPO Equity
Technology:
Regenerative Medicine
Investor Type:
Company
Founded Date:
Undisclosed
Industry:
Regenerative Medicine